Published in Eur J Heart Fail on January 01, 2004
Gata4 is required for maintenance of postnatal cardiac function and protection from pressure overload-induced heart failure. Proc Natl Acad Sci U S A (2006) 1.73
CaMKII negatively regulates calcineurin-NFAT signaling in cardiac myocytes. Circ Res (2009) 1.33
Cardiac anti-remodelling effect of aerobic training is associated with a reduction in the calcineurin/NFAT signalling pathway in heart failure mice. J Physiol (2009) 1.08
NFATc4 is negatively regulated in miR-133a-mediated cardiomyocyte hypertrophic repression. Am J Physiol Heart Circ Physiol (2010) 1.07
Reversibility of adverse, calcineurin-dependent cardiac remodeling. Circ Res (2011) 1.03
The role of the paracrine/autocrine mediator endothelin-1 in regulation of cardiac contractility and growth. Br J Pharmacol (2013) 1.00
Role of the Wnt-Frizzled system in cardiac pathophysiology: a rapidly developing, poorly understood area with enormous potential. J Physiol (2012) 0.98
Cardioprotection of controlled and cardiac-specific over-expression of A(2A)-adenosine receptor in the pressure overload. PLoS One (2012) 0.95
Transcription factor GATA4 is activated but not required for insulin-like growth factor 1 (IGF1)-induced cardiac hypertrophy. J Biol Chem (2012) 0.92
Transcription factors in heart: promising therapeutic targets in cardiac hypertrophy. Curr Cardiol Rev (2011) 0.86
A new twist on an old idea part 2: cyclosporine preserves normal mitochondrial but not cardiomyocyte function in mini-swine with compensated heart failure. Physiol Rep (2014) 0.85
Changes in Cx43 and NaV1.5 expression precede the occurrence of substantial fibrosis in calcineurin-induced murine cardiac hypertrophy. PLoS One (2014) 0.84
Calcineurin and Akt expression in hypertrophied bladder in STZ-induced diabetic rat. Exp Mol Pathol (2012) 0.78
Hyperphosphate-Induced Myocardial Hypertrophy through the GATA-4/NFAT-3 Signaling Pathway Is Attenuated by ERK Inhibitor Treatment. Cardiorenal Med (2015) 0.77
Activation of calcineurin in human failing heart ventricle by endothelin-1, angiotensin II and urotensin II. Br J Pharmacol (2005) 0.77
Dkk3 prevents familial dilated cardiomyopathy development through Wnt pathway. Lab Invest (2015) 0.75
Analyzing gene expression profiles in dilated cardiomyopathy via bioinformatics methods. Braz J Med Biol Res (2016) 0.75
Proteomic and metabolomic changes driven by elevating myocardial creatine suggest novel metabolic feedback mechanisms. Amino Acids (2016) 0.75
Myocardial transcription factors in diastolic dysfunction: clues for model systems and disease. Heart Fail Rev (2016) 0.75
Ouabain-like compound changes rapidly on physical exercise in humans and dogs: effects of beta-blockade and angiotensin-converting enzyme inhibition. Hypertension (2005) 2.38
Early detection of mechanical valve dysfunction using a new home monitoring device. Ann Thorac Surg (2007) 2.18
Effective engraftment but poor mid-term persistence of mononuclear and mesenchymal bone marrow cells in acute and chronic rat myocardial infarction. J Mol Cell Cardiol (2006) 1.72
Reevaluation of direct true lumen cannulation in surgery for acute type A aortic dissection. Ann Thorac Surg (2009) 1.53
Basic fibroblast growth factor controls migration in human mesenchymal stem cells. Stem Cells (2006) 1.52
Sarcoplasmic reticulum Ca2+-ATPase modulates cardiac contraction and relaxation. Cardiovasc Res (2003) 1.38
A mutation in calsequestrin, CASQ2D307H, impairs Sarcoplasmic Reticulum Ca2+ handling and causes complex ventricular arrhythmias in mice. Cardiovasc Res (2007) 1.30
Levosimendan: molecular mechanisms and clinical implications: consensus of experts on the mechanisms of action of levosimendan. Int J Cardiol (2011) 1.24
Mesenchymal stem cells transmigrate over the endothelial barrier. Eur J Cell Biol (2006) 1.18
Large-dose hydroxyethyl starch 130/0.4 does not increase blood loss and transfusion requirements in coronary artery bypass surgery compared with hydroxyethyl starch 200/0.5 at recommended doses. Anesthesiology (2003) 1.17
Platelet sarcoplasmic endoplasmic reticulum Ca2+-ATPase and mu-calpain activity are altered in type 2 diabetes mellitus and restored by rosiglitazone. Circulation (2007) 1.13
Crataegus special extract WS 1442 induces an endothelium-dependent, NO-mediated vasorelaxation via eNOS-phosphorylation at serine 1177. Cardiovasc Drugs Ther (2006) 1.10
Isometric force kinetics upon rapid activation and relaxation of mouse, guinea pig and human heart muscle studied on the subcellular myofibrillar level. Basic Res Cardiol (2002) 1.08
Impact of cardiopulmonary bypass management on postcardiac surgery renal function. Perfusion (2002) 1.04
Mechanisms of beta 3-adrenoceptor-induced eNOS activation in right atrial and left ventricular human myocardium. Br J Pharmacol (2004) 1.02
Modulation of SERCA: implications for the failing human heart. Basic Res Cardiol (2002) 1.02
The angiotensin-calcineurin-NFAT pathway mediates stretch-induced up-regulation of matrix metalloproteinases-2/-9 in atrial myocytes. Basic Res Cardiol (2009) 1.01
The cardiac sodium pump: structure and function. Basic Res Cardiol (2002) 1.00
First year changes of myocardial lymphatic endothelial markers in heart transplant recipients. Eur J Cardiothorac Surg (2006) 0.98
How to do it: direct true lumen cannulation technique of the ascending aorta in acute aortic dissection type A. Interact Cardiovasc Thorac Surg (2012) 0.98
Losartan prevents stretch-induced electrical remodeling in cultured atrial neonatal myocytes. Am J Physiol Heart Circ Physiol (2007) 0.97
Beta3-adrenergic eNOS stimulation in left ventricular murine myocardium. Can J Physiol Pharmacol (2006) 0.97
Na(+)--Ca2+ exchange in the regulation of cardiac excitation-contraction coupling. Cardiovasc Res (2005) 0.96
The simultaneous measurement of ionized and total calcium and ionized and total magnesium in intensive care unit patients. J Crit Care (2002) 0.96
Enhanced heterogeneity of myocardial conduction and severe cardiac electrical instability in annexin A7-deficient mice. Cardiovasc Res (2007) 0.95
Evidence for calcineurin-mediated regulation of SERCA 2a activity in human myocardium. J Mol Cell Cardiol (2002) 0.95
Effects of the beta3-adrenergic agonist BRL 37344 on endothelial nitric oxide synthase phosphorylation and force of contraction in human failing myocardium. J Card Fail (2008) 0.93
Bucindolol exerts agonistic activity on the propranolol-insensitive state of beta1-adrenoceptors in human myocardium. J Pharmacol Exp Ther (2002) 0.93
Cardioplegic arrest induces apoptosis signal-pathway in myocardial endothelial cells and cardiac myocytes. Eur J Cardiothorac Surg (2003) 0.93
Daily assessment of organ dysfunction and survival in intensive care unit cardiac surgical patients. Ann Thorac Surg (2005) 0.93
A simple device to apply equibiaxial strain to cells cultured on flexible membranes. Am J Physiol Heart Circ Physiol (2007) 0.92
Role of balloon occlusion for mononuclear bone marrow cell deposition after intracoronary injection in pigs with reperfused myocardial infarction. Eur Heart J (2008) 0.92
N-acetylcysteine prevents reactive oxygen species-mediated myocardial stress in patients undergoing cardiac surgery: results of a randomized, double-blind, placebo-controlled clinical trial. J Thorac Cardiovasc Surg (2003) 0.91
Isoform specificity of cardiac glycosides binding to human Na+,K+-ATPase alpha1beta1, alpha2beta1 and alpha3beta1. Eur J Pharmacol (2009) 0.88
Incidence and outcome of gastrointestinal complications after cardiopulmonary bypass. Interact Cardiovasc Thorac Surg (2006) 0.88
Sodium pump isoform expression in heart failure: implication for treatment. Basic Res Cardiol (2002) 0.88
Regulation of nerve growth factor in the heart: the role of the calcineurin-NFAT pathway. J Mol Cell Cardiol (2008) 0.88
Beneficial effects of the Ca(2+) sensitizer levosimendan in human myocardium. Am J Physiol Heart Circ Physiol (2002) 0.88
Induction of cardioplegic arrest immediately activates the myocardial apoptosis signal pathway. Am J Physiol Heart Circ Physiol (2006) 0.87
Administration of testosterone is associated with a reduced susceptibility to myocardial ischemia. Endocrinology (2003) 0.87
Mild hypothermia impairs left ventricular diastolic but not systolic function. J Invest Surg (2005) 0.86
Cardio-selective beta-blocker: pharmacological evidence and their influence on exercise capacity. Cardiovasc Ther (2012) 0.86
Genetically changed mice with chronic deficiency or overexpression of the beta-adrenoceptors--what can we learn for the therapy of heart failure? Pflugers Arch (2007) 0.85
Mechanisms of Ca2+-dependent calcineurin activation in mechanical stretch-induced hypertrophy. Cardiology (2007) 0.85
Myocardial apoptosis prevention by radical scavenging in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg (2004) 0.85
TNF and congestive heart failure: therapeutic possibilities. Expert Opin Ther Targets (2004) 0.85
The antioxidant N-acetylcysteine preserves myocardial function and diminishes oxidative stress after cardioplegic arrest. J Thorac Cardiovasc Surg (2003) 0.84
Reduced sarcoplasmic reticulum Ca2+ -ATPase activity and dephosphorylated phospholamban contribute to contractile dysfunction in human hibernating myocardium. Mol Cell Biochem (2006) 0.84
Symptomatic relief precedes improvement of myocardial blood flow in patients under spinal cord stimulation. Curr Control Trials Cardiovasc Med (2005) 0.84
Alterations of tension-dependent ATP utilization in a transgenic rat model of hypertrophic cardiomyopathy. J Biol Chem (2006) 0.83
Loss of the serum response factor cofactor, cysteine-rich protein 1, attenuates neointima formation in the mouse. Arterioscler Thromb Vasc Biol (2010) 0.83
Ser16-, but not Thr17-phosphorylation of phospholamban influences frequency-dependent force generation in human myocardium. Pflugers Arch (2003) 0.83
Ca2+-dependent modulation of single human cardiac L-type calcium channels by the calcineurin inhibitor cyclosporine. J Mol Cell Cardiol (2004) 0.83
Sympathetic neurons express and secrete MMP-2 and MT1-MMP to control nerve sprouting via pro-NGF conversion. Cell Mol Neurobiol (2010) 0.82
Increased Ca2+ sensitivity and protein expression of SERCA 2a in situations of chronic beta3-adrenoceptor deficiency. Pflugers Arch (2006) 0.82
Isoform-specific downregulation of peroxiredoxin in human failing myocardium. Life Sci (2007) 0.82
Electrical stimulation of sympathetic neurons induces autocrine/paracrine effects of NGF mediated by TrkA. J Mol Cell Cardiol (2010) 0.82
eNOS translocation but not eNOS phosphorylation is dependent on intracellular Ca2+ in human atrial myocardium. Am J Physiol Cell Physiol (2005) 0.82
Role of erythropoietin for angiogenesis and vasculogenesis: from embryonic development through adulthood. Am J Physiol Heart Circ Physiol (2005) 0.82
Pneumocyte apoptosis induction during cardiopulmonary bypass: effective prevention by radical scavenging using N-acetylcysteine. J Invest Surg (2007) 0.82
Mechanisms underlying nebivolol-induced endothelial nitric oxide synthase activation in human umbilical vein endothelial cells. Clin Exp Pharmacol Physiol (2006) 0.81
Increased Ca2+-sensitivity of myofibrillar tension in heart failure and its functional implication. Basic Res Cardiol (2002) 0.81
Beta 1-adrenoceptor selectivity of nebivolol and bisoprolol. A comparison of [3H]CGP 12.177 and [125I]iodocyanopindolol binding studies. Eur J Pharmacol (2003) 0.81
Nebivolol lowers blood pressure and increases weight loss in patients with hypertension and diabetes in regard to age. J Cardiovasc Pharmacol (2010) 0.81
Extracorporeal circulation activates endothelial nitric oxide synthase in erythrocytes. Ann Thorac Surg (2007) 0.80
Mechanical stretch induces nerve sprouting in rat sympathetic neurocytes. Auton Neurosci (2010) 0.80
Cellular cardiomyoplasty--a novel approach to treat heart disease. Congest Heart Fail (2002) 0.80
Na+/Ca2+ exchanger overexpression impairs frequency- and ouabain-dependent cell shortening in adult rat cardiomyocytes. Am J Physiol Heart Circ Physiol (2004) 0.80
Reduced length-dependent cross-bridge recruitment in skinned fiber preparations of human failing myocardium. Eur J Appl Physiol (2003) 0.80
Compliance of a cobalt chromium coronary stent alloy--the COVIS trial. Curr Control Trials Cardiovasc Med (2005) 0.80
Mechanical stretch of sympathetic neurons induces VEGF expression via a NGF and CNTF signaling pathway. Biochem Biophys Res Commun (2011) 0.80
[Reverse remodeling of the intracellular Ca(2+)-homeostasis: new concepts of pathophysiology and therapy of heart failure]. Wien Med Wochenschr (2006) 0.79
Renal protection by radical scavenging in cardiac surgery patients. Curr Med Res Opin (2005) 0.79
Impact of antioxidative treatment on nuclear factor kappa-B regulation during myocardial ischemia-reperfusion. Interact Cardiovasc Thorac Surg (2006) 0.79
Sarcoplasmic Ca2+ release is prolonged in nonfailing myocardium of diabetic patients. Mol Cell Biochem (2007) 0.79
Phospho-eNOS Ser-114 in human mesenchymal stem cells: constitutive phosphorylation, nuclear localization and upregulation during mitosis. Eur J Cell Biol (2005) 0.79
[Treatment of cardiogenic shock with the Ca2+ sensitizer levosimendan]. Med Klin (Munich) (2004) 0.78
Calcium handling in human heart failure--abnormalities and target for therapy. Wien Med Wochenschr (2012) 0.78
Increased Ca2+ sensitivity of myofibrillar tension in ischaemic vs dilated cardiomyopathy. Clin Exp Pharmacol Physiol (2010) 0.78
Age-related regional differences in cardiac nerve growth factor expression. Age (Dordr) (2011) 0.78
[Physical activity and endothelial dysfunction in type 2 diabetic patients: the role of nitric oxide and oxidative stress]. Wien Med Wochenschr (2011) 0.78
Mesenchymal stem cells induce endothelial activation via paracine mechanisms. Endothelium (2007) 0.78
[On the function of beta3-adrenoceptors in the human heart: signal transduction, inotropic effect and therapeutic prospects]. Wien Med Wochenschr (2006) 0.78
The Modified Glasgow Outcome Score for the prediction of outcome in patients after cardiac arrest: a prospective clinical proof of concept study. Clin Res Cardiol (2012) 0.77
Transmurality of scar influences the effect of a hybrid-intervention with autologous bone marrow cell injection and aortocoronary bypass surgery (MNC/CABG) in patients after myocardial infarction. Int J Cardiol (2010) 0.77